Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
16.59
-0.33 (-1.95%)
At close: Dec 31, 2025, 4:00 PM EST
16.66
+0.07 (0.42%)
After-hours: Dec 31, 2025, 7:24 PM EST

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
Vonoprazan
55.25M
Log In
Vonoprazan Growth
8001.47%
Log In

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
United States
55.25M
Log In
United States Growth
8001.47%
Log In